» Articles » PMID: 37124540

Preoperative Strain Ultrasound Elastography Can Predict Occult Central Cervical Lymph Node Metastasis in Papillary Thyroid Cancer: a Single-center Retrospective Study

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 May 1
PMID 37124540
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether preoperative ultrasound elastography can predict occult central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid cancer.

Methods: This retrospective study included 541 papillary thyroid cancer patients with clinically negative lymph nodes prior to surgery between July 2019 and December 2021. Based on whether CCLNM was present on postoperative pathology, patients were categorized as CCLNM (+) or CCLNM (-). Preoperative clinical data, conventional ultrasound features, and ultrasound elastography indices were compared between the groups. Univariate and multivariate logistic regression analysis were performed to identify the independent predictors of occult CCLNM.

Results: A total of 36.60% (198/541) patients had confirmed CCLNM, while 63.40% (343/541) did not. Tumor location, bilaterality, multifocality, echogenicity, margin, shape, vascularity, capsule contact, extrathyroidal extension, aspect ratio, and shear wave elasticity parameters were comparable between the groups (all > 0.05). Univariate analysis showed statistically significant differences between the two groups in age, sex, tumor size, calcification, capsule invasion, and strain rates ratio in strain ultrasound elastography (all < 0.05). In multivariate logistic regression analysis, the independent predictors of occult CCLNM were age (OR = 0.975, 95% CI = 0.959-0.991, = 0.002), sex (OR = 1.886, 95% CI = 1.220-2.915, = 0.004), tumor size (OR = 1.054, 95% CI = 1.014-1.097, = 0.008), and strain rates ratio (OR = 1.178, 95% CI = 1.065-1.304, = 0.002).

Conclusion: Preoperative strain ultrasound elastography can predict presence of occult CCLNM in papillary thyroid cancer patients and help clinicians select the appropriate treatment strategy.

Citing Articles

Ultrasound-guided radiofrequency ablation for isthmus papillary thyroid microcarcinoma: a prospective 2 years of follow-up study.

Wang C, Niu Y, Zhang L, Zhang T, Bai J Updates Surg. 2025; .

PMID: 39865211 DOI: 10.1007/s13304-025-02085-5.


How Many Lymph Nodes are Enough in Thyroidectomy? A Cohort Study Based on Real-World Data.

Wei B, Tan H, Chen L, Chang S, Wang W Ann Surg Oncol. 2024; 32(2):1149-1157.

PMID: 39521741 DOI: 10.1245/s10434-024-16391-6.


Predictive Values of Clinical Features and Multimodal Ultrasound for Central Lymph Node Metastases in Papillary Thyroid Carcinoma.

Fu J, Liu J, Wang Z, Qian L Diagnostics (Basel). 2024; 14(16).

PMID: 39202260 PMC: 11353660. DOI: 10.3390/diagnostics14161770.


Predictive value of an ultrasound-based radiomics model for central lymph node metastasis of papillary thyroid carcinoma.

Jia W, Cai Y, Wang S, Wang J Int J Med Sci. 2024; 21(9):1701-1709.

PMID: 39006837 PMC: 11241091. DOI: 10.7150/ijms.95022.


Application of strain elastography ultrasound to the endometrium of normal women.

Shen G, Zhang X, Qin L, Wu Y, Li H BMC Med Imaging. 2024; 24(1):153.

PMID: 38902645 PMC: 11188229. DOI: 10.1186/s12880-024-01327-z.

References
1.
Wang L, Xu D, Yang Y, Li M, Zheng C, Qiu X . Safety and efficacy of ultrasound-guided percutaneous thermal ablation in treating low-risk papillary thyroid microcarcinoma: A pilot and feasibility study. J Cancer Res Ther. 2020; 15(7):1522-1529. DOI: 10.4103/jcrt.JCRT_214_19. View

2.
Xue S, Wang P, Liu J, Li R, Zhang L, Chen G . Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: A retrospective study in China. Asian J Surg. 2015; 39(3):131-6. DOI: 10.1016/j.asjsur.2015.03.015. View

3.
Yao F, Yang Z, Li Y, Chen W, Wu T, Peng J . Real-World Evidence on the Sensitivity of Preoperative Ultrasound in Evaluating Central Lymph Node Metastasis of Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne). 2022; 13:865911. PMC: 9223469. DOI: 10.3389/fendo.2022.865911. View

4.
Conzo G, Tartaglia E, Avenia N, Giorgio Calo P, De Bellis A, Esposito K . Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends. World J Surg Oncol. 2016; 14:149. PMC: 4869299. DOI: 10.1186/s12957-016-0879-4. View

5.
Sessa L, Lombardi C, De Crea C, Tempera S, Bellantone R, Raffaelli M . Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma. World J Surg. 2017; 42(3):623-629. DOI: 10.1007/s00268-017-4390-z. View